Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients

Authors:	Preetesh Jain MBBS MD DM PhD Hagop M. Kantarjian MD Ahmad Ghorab MD Koji Sasaki MD Elias J. Jabbour MD Graciela Nogueras Gonzalez MD Rashmi Kanagal‐Shamanna MD Ghayas C. Issa MD Guillermo Garcia‐Manero MD Devendra KC MD Sara Dellasala MD Sherry Pierce MD Marina Konopleva MD William G. Wierda MD PhD Srdan Verstovsek MD PhD Naval G. Daver MD Tapan M. Kadia MD Gautam Borthakur MD Susan O'Brien MD Zeev Estrov MD Farhad Ravandi MD Jorge E. Cortes MD

Affiliation:	1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas;2. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Abstract:

Keywords:	blast phase (BP) bosutinib chronic myeloid leukemia (CML) dasatinib imatinib nilotinib ponatinib tyrosine kinase inhibitors (TKI)